- Published on
Ophthalmology – Conjunctival and Corneal Foreign Bodies
Conjunctival and corneal foreign bodies are among the most common ophthalmic emergencies, typically involving small particles such as metal, dust, or organic material that become lodged in the conjunctiva or cornea. These injuries frequently occur in young males and are often work-related, especially with activities involving power tools or exposure to wind-blown debris. Proper use of protective eyewear is the most effective preventive measure.
Patients usually present with acute eye pain, foreign body sensation, tearing, redness, and photophobia, which are often relieved temporarily by topical anesthetics. A key aspect of history is identifying the mechanism and velocity of injury, as high-velocity injuries (e.g., metal-on-metal) raise concern for a serious intraocular foreign body (IOFB) or globe penetration, which must not be missed.
On examination, findings may include conjunctival injection, eyelid swelling, corneal epithelial defect, or a visible foreign body. Metallic foreign bodies may leave a rust ring, and long-standing foreign bodies can cause inflammation, infection, or corneal necrosis. A careful slit-lamp examination is essential to determine the location and depth of the foreign body. Fluorescein staining helps identify epithelial defects, and the eyelids should always be everted to check for hidden particles. Warning signs such as decreased vision, irregular pupil, hyphema, or shallow/deep anterior chamber should raise suspicion for globe injury or IOFB.
If needed, imaging such as CT scan or ultrasound can help detect intraocular foreign bodies. MRI should be avoided if a metallic foreign body is suspected. A positive Seidel test indicates aqueous leakage and confirms globe penetration.
Treatment begins with careful removal of the foreign body under topical anesthesia using irrigation, a cotton tip, forceps, or a specialized spud. After removal, topical antibiotics (commonly fluoroquinolones) are prescribed to prevent infection. Cycloplegics may be added for associated inflammation, and oral analgesics can be used for pain. Importantly, topical anesthetics should never be prescribed for home use, as they can delay healing and cause corneal damage.
Close follow-up is essential. Conjunctival foreign bodies are typically reviewed in 48–72 hours, while corneal injuries require more frequent follow-up (every 24–48 hours) until healing occurs. The prognosis is generally excellent for superficial injuries, but complications such as infection, inflammation, or corneal scarring can occur if not managed appropriately.
Conjunctival and corneal foreign bodies are among the most common ophthalmic emergencies, typically involving small particles such as metal, dust, or organic material that become lodged in the conjunctiva or cornea. These injuries frequently occur in young males and are often work-related, especially with activities involving power tools or exposure to wind-blown debris. Proper use of protective eyewear is the most effective preventive measure.
Patients usually present with acute eye pain, foreign body sensation, tearing, redness, and photophobia, which are often relieved temporarily by topical anesthetics. A key aspect of history is identifying the mechanism and velocity of injury, as high-velocity injuries (e.g., metal-on-metal) raise concern for a serious intraocular foreign body (IOFB) or globe penetration, which must not be missed.
On examination, findings may include conjunctival injection, eyelid swelling, corneal epithelial defect, or a visible foreign body. Metallic foreign bodies may leave a rust ring, and long-standing foreign bodies can cause inflammation, infection, or corneal necrosis. A careful slit-lamp examination is essential to determine the location and depth of the foreign body. Fluorescein staining helps identify epithelial defects, and the eyelids should always be everted to check for hidden particles. Warning signs such as decreased vision, irregular pupil, hyphema, or shallow/deep anterior chamber should raise suspicion for globe injury or IOFB.
If needed, imaging such as CT scan or ultrasound can help detect intraocular foreign bodies. MRI should be avoided if a metallic foreign body is suspected. A positive Seidel test indicates aqueous leakage and confirms globe penetration.
Treatment begins with careful removal of the foreign body under topical anesthesia using irrigation, a cotton tip, forceps, or a specialized spud. After removal, topical antibiotics (commonly fluoroquinolones) are prescribed to prevent infection. Cycloplegics may be added for associated inflammation, and oral analgesics can be used for pain. Importantly, topical anesthetics should never be prescribed for home use, as they can delay healing and cause corneal damage.
Close follow-up is essential. Conjunctival foreign bodies are typically reviewed in 48–72 hours, while corneal injuries require more frequent follow-up (every 24–48 hours) until healing occurs. The prognosis is generally excellent for superficial injuries, but complications such as infection, inflammation, or corneal scarring can occur if not managed appropriately.
- Published on
Ophthalmology – Congenital Pit of the Optic Disc
Congenital pit of the optic disc is a rare developmental anomaly characterized by a small, round, grayish excavation in the optic nerve head. It is usually unilateral and often discovered incidentally during routine examination. However, it can become clinically significant when associated with serous macular detachment, leading to visual symptoms.
The condition is thought to arise from incomplete closure of the embryonic fissure, resulting in a structural defect of the optic nerve head. Fluid dynamics play a key role in its complications. The most widely accepted mechanism suggests that liquefied vitreous fluid enters through the optic pit into the subretinal space, leading to a characteristic two-layered maculopathy: inner retinal schisis and outer retinal detachment. Vitreomacular traction may also contribute to fluid accumulation.
Patients are often asymptomatic if the pit is isolated. When macular involvement occurs, symptoms include blurred vision, metamorphopsia, micropsia, or paracentral scotoma. On examination, the pit appears as a small hypopigmented depression, most commonly located on the temporal side of the optic disc. Visual field defects, particularly arcuate scotomas, may be present. Up to 40–50% of cases develop serous macular detachment, especially with larger or temporally located pits.
Diagnosis is primarily clinical but supported by imaging. Optical coherence tomography (OCT) is essential and typically shows schisis-like separation of retinal layers with subretinal fluid. Fluorescein angiography is usually unremarkable but may show late staining of the pit. Visual field testing helps document functional deficits.
Management depends on the presence of complications. Asymptomatic pits require observation with regular follow-up. In cases with serous macular detachment, treatment options include laser photocoagulation, pars plana vitrectomy with internal tamponade, and sometimes macular buckling. Among these, vitrectomy with induction of posterior vitreous detachment has shown the most favorable long-term outcomes.
The prognosis is variable. While the optic pit itself is typically stable, associated macular detachment can lead to progressive visual loss. Many patients experience significant decline in visual acuity over time, although rare cases of spontaneous resolution have been reported. The main complication is serous macular detachment, which is responsible for most visual morbidity.
Congenital pit of the optic disc is a rare developmental anomaly characterized by a small, round, grayish excavation in the optic nerve head. It is usually unilateral and often discovered incidentally during routine examination. However, it can become clinically significant when associated with serous macular detachment, leading to visual symptoms.
The condition is thought to arise from incomplete closure of the embryonic fissure, resulting in a structural defect of the optic nerve head. Fluid dynamics play a key role in its complications. The most widely accepted mechanism suggests that liquefied vitreous fluid enters through the optic pit into the subretinal space, leading to a characteristic two-layered maculopathy: inner retinal schisis and outer retinal detachment. Vitreomacular traction may also contribute to fluid accumulation.
Patients are often asymptomatic if the pit is isolated. When macular involvement occurs, symptoms include blurred vision, metamorphopsia, micropsia, or paracentral scotoma. On examination, the pit appears as a small hypopigmented depression, most commonly located on the temporal side of the optic disc. Visual field defects, particularly arcuate scotomas, may be present. Up to 40–50% of cases develop serous macular detachment, especially with larger or temporally located pits.
Diagnosis is primarily clinical but supported by imaging. Optical coherence tomography (OCT) is essential and typically shows schisis-like separation of retinal layers with subretinal fluid. Fluorescein angiography is usually unremarkable but may show late staining of the pit. Visual field testing helps document functional deficits.
Management depends on the presence of complications. Asymptomatic pits require observation with regular follow-up. In cases with serous macular detachment, treatment options include laser photocoagulation, pars plana vitrectomy with internal tamponade, and sometimes macular buckling. Among these, vitrectomy with induction of posterior vitreous detachment has shown the most favorable long-term outcomes.
The prognosis is variable. While the optic pit itself is typically stable, associated macular detachment can lead to progressive visual loss. Many patients experience significant decline in visual acuity over time, although rare cases of spontaneous resolution have been reported. The main complication is serous macular detachment, which is responsible for most visual morbidity.
- Published on
Ophthalmology – Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE)
Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE) consists of benign melanocytic lesions of the retinal pigment epithelium (RPE). These lesions may be solitary, grouped, or multiple, and their clinical significance ranges from harmless incidental findings to markers of systemic disease.
CHRPE lesions are typically flat, well-demarcated, and darkly pigmented, appearing gray-brown to jet black. Many lesions show characteristic depigmented lacunae (pale areas) or a surrounding halo. They are most commonly located in the superotemporal fundus and usually measure about 1–2 disc diameters, though larger lesions can occur.
Three main patterns are recognized:
1. Solitary CHRPE
These are single, flat lesions with smooth or scalloped borders. They may slowly enlarge over time and can develop increasing depigmentation. They are generally benign and not associated with systemic disease.
2. Grouped CHRPE (“bear tracks”)
These consist of multiple small, round pigmented spots arranged in clusters. They are often unilateral and confined to one retinal quadrant. Despite their striking appearance, they have no systemic associations and are considered benign variants.
3. Multiple bilateral CHRPE associated with Familial adenomatous polyposis
This pattern is clinically important. Lesions are typically:
• Multiple (>4 per eye)
• Bilateral
• Oval with irregular borders
• Often show “fishtail” depigmentation at the edges
These findings may indicate an underlying mutation in the APC gene, a tumor suppressor gene responsible for familial adenomatous polyposis (FAP).
Epidemiologically, CHRPE is found in approximately 1.2% of the population, while FAP occurs in about 1 in 13,000–18,000 individuals. Notably, 70–80% of patients with FAP have CHRPE-like lesions, making this an important ocular marker.
Pathophysiologically, CHRPE arises from hypertrophy and hyperplasia of RPE cells, which contain abundant melanin. Solitary and grouped lesions are typically composed of a single layer of enlarged pigmented cells, while FAP-associated lesions may show multilayering and retinal involvement.
History is crucial, especially in patients with multiple lesions. Clinicians should ask about:
• Family history of colon cancer or polyps
• Gastrointestinal symptoms (e.g., rectal bleeding, abdominal pain)
• Associated tumors or syndromes
On examination, dilated funduscopy reveals the characteristic pigmented lesions. The presence of bilateral, multiple, widely spaced lesions should raise suspicion for FAP and prompt systemic evaluation.
Diagnostic tools include:
• Fundus photography for documentation and monitoring
• Autofluorescence imaging (lesions appear hypoautofluorescent)
• Fluorescein angiography (may show capillary changes)
• Visual field testing (for large lesions causing scotomas)
If FAP is suspected, referral for genetic testing (APC gene) and gastrointestinal evaluation is essential. Screening with colonoscopy or sigmoidoscopy typically begins in childhood (around age 10).
Management depends on the type:
• Solitary and grouped CHRPE: No treatment required; routine observation
• FAP-associated CHRPE: Requires systemic surveillance and management, including possible colectomy depending on polyp burden
Follow-up includes periodic ophthalmic examination with photographic documentation to monitor for growth or changes.
Prognosis for isolated CHRPE is excellent. Lesions may enlarge slowly and can cause localized retinal atrophy, occasionally leading to visual field defects.
The most critical complication is not ocular but systemic--risk of colorectal carcinoma in patients with FAP. Rarely, malignant transformation of CHRPE itself has been reported, but this is exceedingly uncommon.
Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE) consists of benign melanocytic lesions of the retinal pigment epithelium (RPE). These lesions may be solitary, grouped, or multiple, and their clinical significance ranges from harmless incidental findings to markers of systemic disease.
CHRPE lesions are typically flat, well-demarcated, and darkly pigmented, appearing gray-brown to jet black. Many lesions show characteristic depigmented lacunae (pale areas) or a surrounding halo. They are most commonly located in the superotemporal fundus and usually measure about 1–2 disc diameters, though larger lesions can occur.
Three main patterns are recognized:
1. Solitary CHRPE
These are single, flat lesions with smooth or scalloped borders. They may slowly enlarge over time and can develop increasing depigmentation. They are generally benign and not associated with systemic disease.
2. Grouped CHRPE (“bear tracks”)
These consist of multiple small, round pigmented spots arranged in clusters. They are often unilateral and confined to one retinal quadrant. Despite their striking appearance, they have no systemic associations and are considered benign variants.
3. Multiple bilateral CHRPE associated with Familial adenomatous polyposis
This pattern is clinically important. Lesions are typically:
• Multiple (>4 per eye)
• Bilateral
• Oval with irregular borders
• Often show “fishtail” depigmentation at the edges
These findings may indicate an underlying mutation in the APC gene, a tumor suppressor gene responsible for familial adenomatous polyposis (FAP).
Epidemiologically, CHRPE is found in approximately 1.2% of the population, while FAP occurs in about 1 in 13,000–18,000 individuals. Notably, 70–80% of patients with FAP have CHRPE-like lesions, making this an important ocular marker.
Pathophysiologically, CHRPE arises from hypertrophy and hyperplasia of RPE cells, which contain abundant melanin. Solitary and grouped lesions are typically composed of a single layer of enlarged pigmented cells, while FAP-associated lesions may show multilayering and retinal involvement.
History is crucial, especially in patients with multiple lesions. Clinicians should ask about:
• Family history of colon cancer or polyps
• Gastrointestinal symptoms (e.g., rectal bleeding, abdominal pain)
• Associated tumors or syndromes
On examination, dilated funduscopy reveals the characteristic pigmented lesions. The presence of bilateral, multiple, widely spaced lesions should raise suspicion for FAP and prompt systemic evaluation.
Diagnostic tools include:
• Fundus photography for documentation and monitoring
• Autofluorescence imaging (lesions appear hypoautofluorescent)
• Fluorescein angiography (may show capillary changes)
• Visual field testing (for large lesions causing scotomas)
If FAP is suspected, referral for genetic testing (APC gene) and gastrointestinal evaluation is essential. Screening with colonoscopy or sigmoidoscopy typically begins in childhood (around age 10).
Management depends on the type:
• Solitary and grouped CHRPE: No treatment required; routine observation
• FAP-associated CHRPE: Requires systemic surveillance and management, including possible colectomy depending on polyp burden
Follow-up includes periodic ophthalmic examination with photographic documentation to monitor for growth or changes.
Prognosis for isolated CHRPE is excellent. Lesions may enlarge slowly and can cause localized retinal atrophy, occasionally leading to visual field defects.
The most critical complication is not ocular but systemic--risk of colorectal carcinoma in patients with FAP. Rarely, malignant transformation of CHRPE itself has been reported, but this is exceedingly uncommon.
- Published on
Ophthalmology – Congenital Hyperpigmented Abnormalities of the Fundus
Congenital hyperpigmented fundus lesions are pigmented abnormalities present at birth, differentiated by their appearance, pattern, and location within the retina or choroid. These lesions arise either from the retinal pigment epithelium (RPE) or melanocytes in the choroid and are usually benign, though some carry systemic associations or require monitoring.
Common entities include:
• Grouped pigmentation (“bear tracks”)
• Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
• Combined hamartoma of the retina and RPE
• Choroidal nevi
• Melanocytoma
• Chorioretinal scars (often from intrauterine infection)
Epidemiologically, these lesions vary in frequency. For example, CHRPE occurs in about 5 per 1,000 individuals, while choroidal nevi are relatively common, present in up to 10–13% of the population.
Risk factors depend on the specific lesion. Notably:
• Multiple or bilateral CHRPE lesions may be associated with Familial adenomatous polyposis
• Combined hamartomas may be associated with Neurofibromatosis type 2
Genetically, CHRPE associated with systemic disease is linked to mutations in the APC gene, while combined hamartomas are associated with NF2 gene mutations. Genetic counseling is recommended when these associations are suspected.
Pathophysiologically, hyperpigmentation results from abnormalities in pigment cell development:
• RPE-derived lesions: CHRPE, grouped pigmentation, combined hamartoma
• Melanocyte-derived lesions: choroidal nevus, melanocytoma
Etiologies include genetic mutations, developmental abnormalities, and in some cases inflammatory or infectious causes (e.g., chorioretinal scars from congenital infections).
Some lesions are associated with systemic disease:
• CHRPE → gastrointestinal polyposis syndromes
• Combined hamartoma → central nervous system tumors (NF2)
• Chorioretinal scars → congenital infections affecting the brain
History should assess:
• Prenatal infection exposure
• Family history of colon cancer or neurologic disease
• Neurologic symptoms (e.g., seizures, developmental delay)
• Exposure risks for infections such as Toxoplasmosis
On examination, a dilated fundus exam is essential. Lesions differ in appearance:
• CHRPE: flat, dark, well-demarcated lesions
• Bear tracks: multiple grouped pigmented spots
• Combined hamartoma: elevated lesion with retinal distortion
• Melanocytoma: deeply pigmented lesion often on the optic nerve
Most lesions are asymptomatic and discovered incidentally, though some may affect vision depending on location.
Diagnostic testing is usually minimal. Imaging such as OCT or B-scan may help characterize lesions. MRI may be indicated when systemic associations (e.g., NF2) are suspected.
Management is generally observation, as most lesions are benign. However:
• Choroidal nevi and melanocytomas require serial monitoring for growth or malignant transformation
• Suspicion of systemic disease warrants referral (e.g., gastroenterology for polyposis syndromes, neurology/neurosurgery for NF2)
Follow-up includes periodic examinations with photo documentation to monitor for changes in size or appearance.
Patient education focuses on:
• Awareness of systemic associations
• Importance of follow-up
• Reporting new visual, neurologic, or hearing symptoms
Prognosis is typically excellent for isolated lesions. However, significance lies in recognizing potential systemic disease associations and rare risks of transformation (e.g., nevus to melanoma).
Congenital hyperpigmented fundus lesions are pigmented abnormalities present at birth, differentiated by their appearance, pattern, and location within the retina or choroid. These lesions arise either from the retinal pigment epithelium (RPE) or melanocytes in the choroid and are usually benign, though some carry systemic associations or require monitoring.
Common entities include:
• Grouped pigmentation (“bear tracks”)
• Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
• Combined hamartoma of the retina and RPE
• Choroidal nevi
• Melanocytoma
• Chorioretinal scars (often from intrauterine infection)
Epidemiologically, these lesions vary in frequency. For example, CHRPE occurs in about 5 per 1,000 individuals, while choroidal nevi are relatively common, present in up to 10–13% of the population.
Risk factors depend on the specific lesion. Notably:
• Multiple or bilateral CHRPE lesions may be associated with Familial adenomatous polyposis
• Combined hamartomas may be associated with Neurofibromatosis type 2
Genetically, CHRPE associated with systemic disease is linked to mutations in the APC gene, while combined hamartomas are associated with NF2 gene mutations. Genetic counseling is recommended when these associations are suspected.
Pathophysiologically, hyperpigmentation results from abnormalities in pigment cell development:
• RPE-derived lesions: CHRPE, grouped pigmentation, combined hamartoma
• Melanocyte-derived lesions: choroidal nevus, melanocytoma
Etiologies include genetic mutations, developmental abnormalities, and in some cases inflammatory or infectious causes (e.g., chorioretinal scars from congenital infections).
Some lesions are associated with systemic disease:
• CHRPE → gastrointestinal polyposis syndromes
• Combined hamartoma → central nervous system tumors (NF2)
• Chorioretinal scars → congenital infections affecting the brain
History should assess:
• Prenatal infection exposure
• Family history of colon cancer or neurologic disease
• Neurologic symptoms (e.g., seizures, developmental delay)
• Exposure risks for infections such as Toxoplasmosis
On examination, a dilated fundus exam is essential. Lesions differ in appearance:
• CHRPE: flat, dark, well-demarcated lesions
• Bear tracks: multiple grouped pigmented spots
• Combined hamartoma: elevated lesion with retinal distortion
• Melanocytoma: deeply pigmented lesion often on the optic nerve
Most lesions are asymptomatic and discovered incidentally, though some may affect vision depending on location.
Diagnostic testing is usually minimal. Imaging such as OCT or B-scan may help characterize lesions. MRI may be indicated when systemic associations (e.g., NF2) are suspected.
Management is generally observation, as most lesions are benign. However:
• Choroidal nevi and melanocytomas require serial monitoring for growth or malignant transformation
• Suspicion of systemic disease warrants referral (e.g., gastroenterology for polyposis syndromes, neurology/neurosurgery for NF2)
Follow-up includes periodic examinations with photo documentation to monitor for changes in size or appearance.
Patient education focuses on:
• Awareness of systemic associations
• Importance of follow-up
• Reporting new visual, neurologic, or hearing symptoms
Prognosis is typically excellent for isolated lesions. However, significance lies in recognizing potential systemic disease associations and rare risks of transformation (e.g., nevus to melanoma).
- Published on
Ophthalmology – Congenital and Pediatric Cataracts
Congenital and pediatric cataracts refer to any opacity of the crystalline lens present at birth or developing during childhood. These cataracts may occur in isolation or in association with ocular abnormalities or systemic disease. Their morphology is highly variable, including forms such as anterior polar, lamellar, nuclear, posterior lenticonus, cerulean, sutural, and total cataracts.
In approximately 60–70% of cases, a cause can be identified, most commonly genetic. The condition may be unilateral or bilateral and can significantly impact visual development if not detected early.
The incidence in the United States is estimated at 1.2–6 per 10,000 children. Risk factors include intrauterine infections, metabolic disorders, trauma (including birth trauma), steroid exposure, uveitis, genetic syndromes, and family history.
Genetically, the most common inheritance pattern is autosomal dominant with variable penetrance, although autosomal recessive and X-linked forms also occur. Numerous genes have been implicated, reflecting the heterogeneity of this condition.
Pathophysiologically, cataract formation results from disruption of normal lens development or metabolism, leading to loss of transparency. The location and type of opacity often reflect the timing of the insult during fetal development or early life.
Etiologies include:
• Idiopathic (most common)
• Genetic mutations
• Intrauterine infections (e.g., Congenital rubella syndrome, toxoplasmosis, CMV, herpes)
• Metabolic disorders such as Galactosemia
• Chromosomal abnormalities (e.g., trisomy 21)
• Drug exposure (e.g., corticosteroids)
Children often present with leukocoria (white pupillary reflex), which may be noticed by parents directly or in photographs. Other presenting signs include strabismus, nystagmus, or poor visual behavior.
A thorough eye examination is essential. This includes:
• Visual assessment (age-appropriate)
• Cycloplegic refraction
• Slit-lamp examination to characterize the cataract
• Fundus examination (if visible)
If the posterior segment cannot be visualized, B-scan ultrasonography is necessary to rule out serious conditions such as Retinoblastoma, retinal detachment, or persistent fetal vasculature.
Laboratory evaluation is guided by clinical suspicion. In bilateral cases, especially with systemic signs, testing may include TORCH titers and metabolic screening (e.g., for galactosemia). Referral to a geneticist is recommended when a syndromic cause is suspected.
The differential diagnosis of leukocoria is broad and includes conditions such as Coats disease, toxocariasis, and retinal detachment, making accurate diagnosis critical.
Management depends on the size, location, and visual significance of the cataract.
• Small (<3 mm), non-central cataracts may be managed conservatively with observation or pharmacologic dilation and occlusion therapy.
• Visually significant cataracts require early surgical removal to prevent amblyopia.
Surgical treatment typically involves lens aspiration, often combined with posterior capsulotomy and anterior vitrectomy in younger children to prevent visual axis opacification. Intraocular lens (IOL) implantation may be performed, though its use in infants under 1–2 years remains controversial. In these cases, contact lenses are often preferred for optical correction.
Postoperative care is critical and includes:
• Refractive correction (glasses or contact lenses)
• Aggressive amblyopia therapy (patching)
• Regular follow-up to monitor visual development
Prognosis depends on several factors, including age at diagnosis, duration of visual deprivation, cataract density, and presence of associated ocular/systemic disease. Early intervention significantly improves visual outcomes.
Complications include:
• Posterior capsule opacification
• Aphakic or pseudophakic glaucoma (may occur years later)
• Retinal detachment
• Infection (endophthalmitis)
• Amblyopia (most critical long-term risk)
Because of the risk of late-onset glaucoma, lifelong monitoring of intraocular pressure is essential, even years after successful cataract surgery.
- Published on
Ophthalmology – Dacryocystitis
Dacryocystitis is an inflammatory condition of the lacrimal sac, most commonly caused by infection and usually occurring as a result of nasolacrimal duct obstruction (NLDO). It may present in acute, chronic, or congenital forms and often leads to recurrent episodes if the underlying obstruction is not addressed. Structural predispositions such as a brachycephalic head shape or a narrow face with a flat nasal bridge may increase susceptibility, although no preventive measures exist prior to the first episode.
The pathophysiology involves stagnation of tears within the lacrimal sac due to obstruction. Normally, the lacrimal drainage system is colonized with bacteria, but continuous tear flow prevents infection. When this flow is blocked, bacteria proliferate, leading to inflammation and infection of the lacrimal sac. Common causative organisms include Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus species, Pneumococcus, as well as gram-negative organisms and anaerobes. Causes of obstruction may include structural abnormalities, nasal inflammation, trauma (such as nasal fractures), punctal plugs, tumors, or cysts.
Clinically, patients typically present with pain, redness, and swelling over the medial canthal region, often accompanied by epiphora (excess tearing). On examination, there is tenderness over the lacrimal sac, a firm swelling below the medial canthus, and purulent discharge from the puncta, especially when pressure is applied. In chronic cases, a dacryocutaneous fistula may develop with spontaneous drainage. Severe or untreated cases can progress to orbital cellulitis, which may present with decreased vision, afferent pupillary defect, and restricted eye movements.
Diagnosis is primarily clinical, based on characteristic history and examination findings. In atypical or refractory cases, further evaluation may be required. Laboratory tests such as CBC or inflammatory markers may be considered if systemic or inflammatory causes are suspected. Cultures of discharge can help guide antibiotic therapy in resistant cases. Imaging, such as CT scanning, may be used to assess structural abnormalities or complications. Additional diagnostic tools like dacryocystography, dacryoscintigraphy, or nasal endoscopy may be used to evaluate the anatomy of the lacrimal drainage system.
Management initially focuses on treating the infection. This includes oral antibiotics, warm compresses, and topical antibiotic drops or ointments. In more severe cases or when there is concern for orbital cellulitis, intravenous antibiotics are required. However, definitive treatment involves addressing the underlying obstruction. Once the acute infection has resolved, a dacryocystorhinostomy (DCR) is typically performed to create a new drainage pathway between the lacrimal sac and the nasal cavity, thereby preventing recurrence. Both external and endonasal approaches are effective, with similar success rates.
The prognosis for dacryocystitis is generally excellent with appropriate treatment, particularly when the underlying obstruction is corrected. However, complications can occur if the condition is not managed promptly. These include orbital cellulitis, which can threaten vision, and in rare severe cases, progression to sepsis and even death. Early recognition and treatment are therefore essential to prevent serious outcomes.
Dacryocystitis is an inflammatory condition of the lacrimal sac, most commonly caused by infection and usually occurring as a result of nasolacrimal duct obstruction (NLDO). It may present in acute, chronic, or congenital forms and often leads to recurrent episodes if the underlying obstruction is not addressed. Structural predispositions such as a brachycephalic head shape or a narrow face with a flat nasal bridge may increase susceptibility, although no preventive measures exist prior to the first episode.
The pathophysiology involves stagnation of tears within the lacrimal sac due to obstruction. Normally, the lacrimal drainage system is colonized with bacteria, but continuous tear flow prevents infection. When this flow is blocked, bacteria proliferate, leading to inflammation and infection of the lacrimal sac. Common causative organisms include Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus species, Pneumococcus, as well as gram-negative organisms and anaerobes. Causes of obstruction may include structural abnormalities, nasal inflammation, trauma (such as nasal fractures), punctal plugs, tumors, or cysts.
Clinically, patients typically present with pain, redness, and swelling over the medial canthal region, often accompanied by epiphora (excess tearing). On examination, there is tenderness over the lacrimal sac, a firm swelling below the medial canthus, and purulent discharge from the puncta, especially when pressure is applied. In chronic cases, a dacryocutaneous fistula may develop with spontaneous drainage. Severe or untreated cases can progress to orbital cellulitis, which may present with decreased vision, afferent pupillary defect, and restricted eye movements.
Diagnosis is primarily clinical, based on characteristic history and examination findings. In atypical or refractory cases, further evaluation may be required. Laboratory tests such as CBC or inflammatory markers may be considered if systemic or inflammatory causes are suspected. Cultures of discharge can help guide antibiotic therapy in resistant cases. Imaging, such as CT scanning, may be used to assess structural abnormalities or complications. Additional diagnostic tools like dacryocystography, dacryoscintigraphy, or nasal endoscopy may be used to evaluate the anatomy of the lacrimal drainage system.
Management initially focuses on treating the infection. This includes oral antibiotics, warm compresses, and topical antibiotic drops or ointments. In more severe cases or when there is concern for orbital cellulitis, intravenous antibiotics are required. However, definitive treatment involves addressing the underlying obstruction. Once the acute infection has resolved, a dacryocystorhinostomy (DCR) is typically performed to create a new drainage pathway between the lacrimal sac and the nasal cavity, thereby preventing recurrence. Both external and endonasal approaches are effective, with similar success rates.
The prognosis for dacryocystitis is generally excellent with appropriate treatment, particularly when the underlying obstruction is corrected. However, complications can occur if the condition is not managed promptly. These include orbital cellulitis, which can threaten vision, and in rare severe cases, progression to sepsis and even death. Early recognition and treatment are therefore essential to prevent serious outcomes.
- Published on
Ophthalmology – Dacryocele
A dacryocele is a distension of the lacrimal sac that typically presents in newborns or early infancy due to congenital obstruction of the nasolacrimal drainage system. It is also referred to as dacryocystocele or lacrimal sac mucocele. Although uncommon, it is an important condition because it can lead to infection or airway compromise. Most cases are sporadic, though rare familial occurrences have been described.
The underlying mechanism involves a dual obstruction of the lacrimal drainage pathway. There is distal blockage at the valve of Hasner combined with proximal functional obstruction at the valve of Rosenmüller. This prevents both forward and backward flow of tears and secretions, leading to accumulation within the lacrimal sac and progressive cystic enlargement. In some infants, an associated intranasal cyst may develop, further worsening obstruction and potentially causing nasal airway compromise.
Clinically, dacryocele presents as a firm, bluish swelling below the medial canthus in a neonate. The mass is typically non-mobile and may cause upward displacement of the lower eyelid. It may occur on one or both sides. In uncomplicated cases, it is painless, but secondary infection can lead to redness, tenderness, and swelling, indicating dacryocystitis or preseptal cellulitis. In severe cases, particularly when an intranasal cyst is present, the infant may develop respiratory distress, as newborns are obligate nasal breathers. Feeding difficulties may also be observed.
Diagnosis is primarily clinical, based on the characteristic appearance. Gentle pressure over the swelling may produce mucoid discharge from the puncta or into the nasal cavity, which supports the diagnosis. If infection is suspected, laboratory investigations such as complete blood count and cultures may be necessary. Imaging studies like CT or MRI are reserved for cases with suspected nasal obstruction or to evaluate for an intranasal cyst, and ENT consultation may be required.
The differential diagnosis includes other medial canthal masses such as capillary hemangioma, dermoid cyst, and encephalocele. These can usually be distinguished based on their clinical features, including color, consistency, mobility, and location.
Initial management often involves conservative treatment with gentle digital massage, which may decompress the cyst. If infection is present, systemic antibiotics are required due to the risk of serious complications. However, many cases, especially those with infection or airway compromise, require surgical intervention. The definitive treatment is probing and irrigation of the nasolacrimal duct, often performed under general anesthesia. Nasal endoscopy may be used to identify and treat associated intranasal cysts, improving success rates.
The prognosis is excellent, with approximately 99% resolution following appropriate surgical management, particularly when nasal endoscopy is utilized. Nevertheless, some infants may later develop typical nasolacrimal duct obstruction.
Complications, although uncommon, include recurrent obstruction, fistula formation if improperly drained externally, and infections such as dacryocystitis, preseptal cellulitis, or even sepsis and meningitis. Parents should be educated on proper massage techniques and advised to watch for warning signs such as redness, swelling, fever, or breathing and feeding difficulties, which require urgent medical evaluation.
A dacryocele is a distension of the lacrimal sac that typically presents in newborns or early infancy due to congenital obstruction of the nasolacrimal drainage system. It is also referred to as dacryocystocele or lacrimal sac mucocele. Although uncommon, it is an important condition because it can lead to infection or airway compromise. Most cases are sporadic, though rare familial occurrences have been described.
The underlying mechanism involves a dual obstruction of the lacrimal drainage pathway. There is distal blockage at the valve of Hasner combined with proximal functional obstruction at the valve of Rosenmüller. This prevents both forward and backward flow of tears and secretions, leading to accumulation within the lacrimal sac and progressive cystic enlargement. In some infants, an associated intranasal cyst may develop, further worsening obstruction and potentially causing nasal airway compromise.
Clinically, dacryocele presents as a firm, bluish swelling below the medial canthus in a neonate. The mass is typically non-mobile and may cause upward displacement of the lower eyelid. It may occur on one or both sides. In uncomplicated cases, it is painless, but secondary infection can lead to redness, tenderness, and swelling, indicating dacryocystitis or preseptal cellulitis. In severe cases, particularly when an intranasal cyst is present, the infant may develop respiratory distress, as newborns are obligate nasal breathers. Feeding difficulties may also be observed.
Diagnosis is primarily clinical, based on the characteristic appearance. Gentle pressure over the swelling may produce mucoid discharge from the puncta or into the nasal cavity, which supports the diagnosis. If infection is suspected, laboratory investigations such as complete blood count and cultures may be necessary. Imaging studies like CT or MRI are reserved for cases with suspected nasal obstruction or to evaluate for an intranasal cyst, and ENT consultation may be required.
The differential diagnosis includes other medial canthal masses such as capillary hemangioma, dermoid cyst, and encephalocele. These can usually be distinguished based on their clinical features, including color, consistency, mobility, and location.
Initial management often involves conservative treatment with gentle digital massage, which may decompress the cyst. If infection is present, systemic antibiotics are required due to the risk of serious complications. However, many cases, especially those with infection or airway compromise, require surgical intervention. The definitive treatment is probing and irrigation of the nasolacrimal duct, often performed under general anesthesia. Nasal endoscopy may be used to identify and treat associated intranasal cysts, improving success rates.
The prognosis is excellent, with approximately 99% resolution following appropriate surgical management, particularly when nasal endoscopy is utilized. Nevertheless, some infants may later develop typical nasolacrimal duct obstruction.
Complications, although uncommon, include recurrent obstruction, fistula formation if improperly drained externally, and infections such as dacryocystitis, preseptal cellulitis, or even sepsis and meningitis. Parents should be educated on proper massage techniques and advised to watch for warning signs such as redness, swelling, fever, or breathing and feeding difficulties, which require urgent medical evaluation.
- Published on
Ophthalmology – Cystoid Macular Edema (CME)
Cystoid macular edema (CME) is a condition characterized by accumulation of fluid within the retinal layers of the macula, particularly in the perifoveal region, leading to blurred or decreased central vision. It represents a final common pathway of many ocular diseases rather than a single disease entity. The most common form is postoperative CME, especially following cataract surgery.
CME occurs due to breakdown of the blood-retinal barrier, resulting in leakage of fluid into the retinal tissue. Although the exact mechanism is not fully understood, contributing factors include inflammation, vitreous traction, and vascular instability. Fluid accumulates either intracellularly (within Müller cells) or extracellularly, forming characteristic cystic spaces.
Clinically, CME may be asymptomatic or present with blurred vision, decreased visual acuity, or metamorphopsia (distorted vision). It is especially important to ask about recent ocular surgery, as well as systemic conditions such as diabetes, uveitis, or hypertension, and medications like prostaglandin analogs or niacin, which may contribute to its development.
On examination, findings include foveal thickening and cystic changes in the macula. However, mild cases may not be easily visible clinically and require imaging. Optical coherence tomography (OCT) is the most sensitive tool, showing increased retinal thickness and cystic spaces, often in the outer plexiform layer, sometimes with subretinal fluid. Fluorescein angiography (FA) classically demonstrates a “petaloid” pattern of dye leakage in the macula along with optic disc hyperfluorescence.
CME has numerous causes, including:
If CME persists, second-line treatments include periocular or intravitreal corticosteroid injections and intravitreal anti-VEGF agents (e.g., bevacizumab). Additional therapies such as oral acetazolamide may be helpful in select cases. In cases related to structural causes like vitreomacular traction or epiretinal membrane, vitrectomy surgery may be required.
Patients should be monitored every 4–6 weeks with OCT to assess response to treatment. Prognosis is generally good for postoperative CME, especially with early detection and appropriate management. However, chronic or untreated CME can lead to permanent vision loss due to macular damage.
Cystoid macular edema (CME) is a condition characterized by accumulation of fluid within the retinal layers of the macula, particularly in the perifoveal region, leading to blurred or decreased central vision. It represents a final common pathway of many ocular diseases rather than a single disease entity. The most common form is postoperative CME, especially following cataract surgery.
CME occurs due to breakdown of the blood-retinal barrier, resulting in leakage of fluid into the retinal tissue. Although the exact mechanism is not fully understood, contributing factors include inflammation, vitreous traction, and vascular instability. Fluid accumulates either intracellularly (within Müller cells) or extracellularly, forming characteristic cystic spaces.
Clinically, CME may be asymptomatic or present with blurred vision, decreased visual acuity, or metamorphopsia (distorted vision). It is especially important to ask about recent ocular surgery, as well as systemic conditions such as diabetes, uveitis, or hypertension, and medications like prostaglandin analogs or niacin, which may contribute to its development.
On examination, findings include foveal thickening and cystic changes in the macula. However, mild cases may not be easily visible clinically and require imaging. Optical coherence tomography (OCT) is the most sensitive tool, showing increased retinal thickness and cystic spaces, often in the outer plexiform layer, sometimes with subretinal fluid. Fluorescein angiography (FA) classically demonstrates a “petaloid” pattern of dye leakage in the macula along with optic disc hyperfluorescence.
CME has numerous causes, including:
- Post-surgical (most common) – especially after cataract surgery
- Diabetic retinopathy
- Retinal vein occlusion
- Uveitis and retinal vasculitis
- Age-related macular degeneration
- Vitreomacular traction or epiretinal membrane
- Drug-induced (e.g., prostaglandins, tamoxifen)
If CME persists, second-line treatments include periocular or intravitreal corticosteroid injections and intravitreal anti-VEGF agents (e.g., bevacizumab). Additional therapies such as oral acetazolamide may be helpful in select cases. In cases related to structural causes like vitreomacular traction or epiretinal membrane, vitrectomy surgery may be required.
Patients should be monitored every 4–6 weeks with OCT to assess response to treatment. Prognosis is generally good for postoperative CME, especially with early detection and appropriate management. However, chronic or untreated CME can lead to permanent vision loss due to macular damage.
- Published on
Ophthalmology – Crystalline Keratopathy
Crystalline keratopathy refers to a group of corneal disorders characterized by crystal-like deposits or branching opacities within the cornea. It is broadly divided into two categories: infectious crystalline keratopathy (ICK) and deposition-related keratopathy. In clinical practice, the term most commonly refers to the infectious form, which is a distinctive, indolent corneal infection marked by minimal inflammation despite microbial presence.
Infectious crystalline keratopathy is an uncommon condition, often associated with corneal grafts, chronic topical steroid use, refractive surgery, contact lens wear, prior herpes simplex keratitis, and systemic immunosuppression. The pathogenesis involves microorganisms colonizing the interlamellar spaces of the corneal stroma, where they produce a biofilm and extracellular matrix. This biofilm shields the organisms from host immune responses and antibiotics, explaining the characteristically minimal inflammatory reaction despite active infection.
The most commonly implicated organisms include Streptococcus viridans, Candida species, and nontuberculous mycobacteria, although infections may be polymicrobial. Patients typically present with gradual visual decline or an incidental finding of a corneal opacity, rather than acute pain or redness.
On examination, the hallmark finding is a white, branching, needle-like crystalline opacity within the anterior corneal stroma, often described as “snowflake” or “tree-like.” Notably, there is little to no surrounding inflammation, which helps distinguish it from typical infectious keratitis. The lesion tends to expand slowly, and anterior chamber reaction is usually absent unless the infection is deeper or more advanced.
Diagnosis relies on corneal scraping or biopsy for culture and sensitivity, although organisms can be difficult to grow due to special nutrient requirements. Additional tools such as corneal optical coherence tomography, confocal microscopy, and PCR testing may aid in detection. In cases where deposition is suspected instead of infection, systemic evaluation (e.g., lipid profile, protein electrophoresis) may be necessary to rule out metabolic or hematologic causes.
Management is often prolonged and challenging. Treatment is organism-specific, typically starting with broad-spectrum topical antibiotics such as fluoroquinolones, then tailored based on culture results. Gram-positive infections may require cefazolin or vancomycin, while gram-negative coverage includes tobramycin or gentamicin. Fungal cases are treated with amphotericin B or voriconazole. Importantly, topical steroids should be reduced or discontinued if possible, as they contribute to disease persistence.
In refractory cases, additional interventions such as Nd:YAG laser disruption of crystals, surgical debridement, or even lamellar or penetrating keratoplasty may be required. Long-term follow-up is essential due to the risk of recurrence or graft failure, particularly in post-transplant patients.
The prognosis is guarded, as the condition is often chronic and resistant to treatment. Complications include persistent infection, corneal scarring, and graft rejection, all of which can significantly impact visual outcomes.
Crystalline keratopathy refers to a group of corneal disorders characterized by crystal-like deposits or branching opacities within the cornea. It is broadly divided into two categories: infectious crystalline keratopathy (ICK) and deposition-related keratopathy. In clinical practice, the term most commonly refers to the infectious form, which is a distinctive, indolent corneal infection marked by minimal inflammation despite microbial presence.
Infectious crystalline keratopathy is an uncommon condition, often associated with corneal grafts, chronic topical steroid use, refractive surgery, contact lens wear, prior herpes simplex keratitis, and systemic immunosuppression. The pathogenesis involves microorganisms colonizing the interlamellar spaces of the corneal stroma, where they produce a biofilm and extracellular matrix. This biofilm shields the organisms from host immune responses and antibiotics, explaining the characteristically minimal inflammatory reaction despite active infection.
The most commonly implicated organisms include Streptococcus viridans, Candida species, and nontuberculous mycobacteria, although infections may be polymicrobial. Patients typically present with gradual visual decline or an incidental finding of a corneal opacity, rather than acute pain or redness.
On examination, the hallmark finding is a white, branching, needle-like crystalline opacity within the anterior corneal stroma, often described as “snowflake” or “tree-like.” Notably, there is little to no surrounding inflammation, which helps distinguish it from typical infectious keratitis. The lesion tends to expand slowly, and anterior chamber reaction is usually absent unless the infection is deeper or more advanced.
Diagnosis relies on corneal scraping or biopsy for culture and sensitivity, although organisms can be difficult to grow due to special nutrient requirements. Additional tools such as corneal optical coherence tomography, confocal microscopy, and PCR testing may aid in detection. In cases where deposition is suspected instead of infection, systemic evaluation (e.g., lipid profile, protein electrophoresis) may be necessary to rule out metabolic or hematologic causes.
Management is often prolonged and challenging. Treatment is organism-specific, typically starting with broad-spectrum topical antibiotics such as fluoroquinolones, then tailored based on culture results. Gram-positive infections may require cefazolin or vancomycin, while gram-negative coverage includes tobramycin or gentamicin. Fungal cases are treated with amphotericin B or voriconazole. Importantly, topical steroids should be reduced or discontinued if possible, as they contribute to disease persistence.
In refractory cases, additional interventions such as Nd:YAG laser disruption of crystals, surgical debridement, or even lamellar or penetrating keratoplasty may be required. Long-term follow-up is essential due to the risk of recurrence or graft failure, particularly in post-transplant patients.
The prognosis is guarded, as the condition is often chronic and resistant to treatment. Complications include persistent infection, corneal scarring, and graft rejection, all of which can significantly impact visual outcomes.
- Published on
41. Ophthalmology – Crouzon Syndrome
Crouzon syndrome is a genetic craniosynostosis disorder characterized by premature fusion of cranial sutures, particularly those of the skull, orbit, and midface. This leads to abnormal development of the cranial vault, orbits, and maxillary complex, producing the classic craniofacial appearance. It occurs in approximately 1 in 60,000 live births and may be inherited in an autosomal dominant pattern or arise from a new (sporadic) mutation. The condition is most commonly associated with mutations in the FGFR2 gene (chromosome 10q25–10q26).
The pathophysiology is based on early suture closure, which restricts skull growth perpendicular to the fused sutures and causes compensatory expansion in other directions. This results in distorted craniofacial anatomy, including shallow orbits and midface hypoplasia. The severity depends on which sutures fuse and how early the fusion occurs.
Ophthalmic manifestations are prominent and often clinically significant. Patients commonly present with proptosis (forward displacement of the eyes) due to shallow orbits, which predisposes to exposure keratopathy, conjunctivitis, and corneal damage. Other ocular findings include hypertelorism (wide-spaced eyes), exotropia (divergent strabismus), refractive errors, and amblyopia. Increased intracranial pressure may lead to papilledema and eventual optic atrophy, resulting in vision loss if untreated. Visual symptoms may include blurred vision, diplopia, irritation, and photophobia.
Systemically, Crouzon syndrome presents with midfacial hypoplasia, a beaked nose, short upper lip, and relative mandibular prognathism. Patients may also develop airway obstruction, obstructive sleep apnea, hearing loss, and dental abnormalities such as a high-arched palate and crowded teeth. A notable associated condition is acanthosis nigricans, presenting as hyperpigmented, velvety skin in flexural areas.
Diagnosis is primarily clinical, supported by genetic testing for FGFR2 mutations. Imaging is essential and includes CT scans with 3D reconstruction to assess cranial suture fusion and orbital anatomy, along with MRI to evaluate intracranial structures and optic nerve status. Additional evaluations often include ophthalmologic exams, audiology testing, and sleep studies.
Management requires a multidisciplinary approach, involving neurosurgery, ophthalmology, craniofacial surgery, and other specialties. Early treatment focuses on cranial decompression (e.g., fronto-orbital advancement) within the first year of life to allow normal brain growth and reduce intracranial pressure. Later procedures, such as midface advancement (e.g., Le Fort III osteotomy), address facial deformities and airway issues. Ophthalmologic care is crucial for preventing amblyopia, managing exposure keratopathy, correcting strabismus, and monitoring optic nerve health.
Long-term follow-up is essential. Patients require ongoing monitoring for vision problems, intracranial pressure changes, and postoperative complications. Prognosis depends on severity, but with timely intervention, most patients can achieve a normal lifespan, although complications such as optic atrophy, airway obstruction, or neurologic impairment may occur if not managed early.
Crouzon syndrome is a genetic craniosynostosis disorder characterized by premature fusion of cranial sutures, particularly those of the skull, orbit, and midface. This leads to abnormal development of the cranial vault, orbits, and maxillary complex, producing the classic craniofacial appearance. It occurs in approximately 1 in 60,000 live births and may be inherited in an autosomal dominant pattern or arise from a new (sporadic) mutation. The condition is most commonly associated with mutations in the FGFR2 gene (chromosome 10q25–10q26).
The pathophysiology is based on early suture closure, which restricts skull growth perpendicular to the fused sutures and causes compensatory expansion in other directions. This results in distorted craniofacial anatomy, including shallow orbits and midface hypoplasia. The severity depends on which sutures fuse and how early the fusion occurs.
Ophthalmic manifestations are prominent and often clinically significant. Patients commonly present with proptosis (forward displacement of the eyes) due to shallow orbits, which predisposes to exposure keratopathy, conjunctivitis, and corneal damage. Other ocular findings include hypertelorism (wide-spaced eyes), exotropia (divergent strabismus), refractive errors, and amblyopia. Increased intracranial pressure may lead to papilledema and eventual optic atrophy, resulting in vision loss if untreated. Visual symptoms may include blurred vision, diplopia, irritation, and photophobia.
Systemically, Crouzon syndrome presents with midfacial hypoplasia, a beaked nose, short upper lip, and relative mandibular prognathism. Patients may also develop airway obstruction, obstructive sleep apnea, hearing loss, and dental abnormalities such as a high-arched palate and crowded teeth. A notable associated condition is acanthosis nigricans, presenting as hyperpigmented, velvety skin in flexural areas.
Diagnosis is primarily clinical, supported by genetic testing for FGFR2 mutations. Imaging is essential and includes CT scans with 3D reconstruction to assess cranial suture fusion and orbital anatomy, along with MRI to evaluate intracranial structures and optic nerve status. Additional evaluations often include ophthalmologic exams, audiology testing, and sleep studies.
Management requires a multidisciplinary approach, involving neurosurgery, ophthalmology, craniofacial surgery, and other specialties. Early treatment focuses on cranial decompression (e.g., fronto-orbital advancement) within the first year of life to allow normal brain growth and reduce intracranial pressure. Later procedures, such as midface advancement (e.g., Le Fort III osteotomy), address facial deformities and airway issues. Ophthalmologic care is crucial for preventing amblyopia, managing exposure keratopathy, correcting strabismus, and monitoring optic nerve health.
Long-term follow-up is essential. Patients require ongoing monitoring for vision problems, intracranial pressure changes, and postoperative complications. Prognosis depends on severity, but with timely intervention, most patients can achieve a normal lifespan, although complications such as optic atrophy, airway obstruction, or neurologic impairment may occur if not managed early.
